PARIS French drugmaker Sanofi said its Sanofi Pasteur unit had signed a long-term cooperation deal with South Korea's SK Chemical Co to develop and market a vaccine against pneumococcal infection.
Under the agreement, Sanofi will make an up-front payment of $23 million to SK Chemical Co, it said in a statement on Wednesday.
Both companies will co-invest in the development of the vaccine project and, if successful, SK Chemical will produce the vaccine at its production facility located in An-dong, in the southern part of Korea.
The product, once registered, will be launched globally by Sanofi Pasteur with shared profits outside of Korea, where SK would commercialize it with exclusive rights.
(Reporting by Dominique Vidalon; Editing by Natalie Huet)
British Airways suffers flight delays after global IT outage
LONDON, May 27 British Airways flights in Britain were being delayed and passengers were suffering long waits at airports on Saturday because of a global system outage, the airline said.
UPDATE 4-Chipotle says hackers hit most restaurants in data breach
May 26 Hackers used malware to steal customer payment data from most of Chipotle Mexican Grill Inc's restaurants over a span of three weeks, the company said on Friday, adding to woes at the chain whose sales had just started recovering from a string of food safety lapses in 2015.